Sonoma Pharmaceuticals earnings were -$3.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SNOA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$776.0k, down 16.4% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, SNOA reported annual earnings of -$3.5M, with -28.5% growth. The next SNOA earnings date is Aug 6, 2025.
Sonoma Pharmaceuticals Earnings Reports & History FAQ
What were Sonoma Pharmaceuticals's earnings last quarter?
Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q1 2025 earnings per share (EPS) of -$0.39, up 454.55% year over year. Total SNOA earnings for the quarter were -$776.00 thousand. In the same quarter last year, Sonoma Pharmaceuticals's earnings per share (EPS) was $0.11.
The next SNOA earnings call is Invalid Date. Add SNOA to your watchlist to be reminded of Sonoma Pharmaceuticals's next earnings date.
What was SNOA's earnings growth in the past year?
As of Sonoma Pharmaceuticals's earnings date in Q3 2025, Sonoma Pharmaceuticals's earnings has grown year over year. SNOA earnings in the past year totalled -$3.46 million.
Is Sonoma Pharmaceuticals profitable or losing money?
As of the last Sonoma Pharmaceuticals earnings report, Sonoma Pharmaceuticals is currently losing money. Sonoma Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$3.46 million, a 28.5% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.